Highlights:
* Today, we announced our results for the first quarter of 2022.
* Underlying sales growth of 7.3%, with 8.3% price and (1.0)% volume
* Turnover increased by 11.8%, including a currency impact of 3.5%
* Quarterly dividend maintained at
* First
* Illustration of a
Statement from
'We are executing well in a very challenging input cost environment. Underlying sales growth of 7.3% was driven by strong pricing, with a limited impact on volume in the quarter. This performance was delivered against the backdrop of significant rises in input costs that have further accelerated through the first three months of the year, and the human tragedy of the war in
'The delivery of another solid quarter of sales growth builds on the improved growth momentum that we achieved in 2021 and is underpinned by
'Our priority markets of the
'There is more to do as we navigate our business through unprecedented cost inflation, but we are making good progress. We are committed to sustaining this step-up in our growth and competitiveness.'
Outlook for 2022
We continue to expect input cost inflation of around
This period of unprecedented inflation requires us to take further pricing action with some impact on volume as a result. We now expect underlying sales growth in 2022 to be towards the top end of the previously guided range of 4.5% to 6.5%. We will ensure that we protect the health of our brands as we continue to invest competitively in marketing, R&D and capital expenditure.
We expect underlying operating margin for the first half to be within our guided 2022 range of 16% to 17%. As a result of the forecast increase in costs in the second half, we currently expect the full year underlying operating margin to be at the bottom end of that range. The greatest area of uncertainty and volatility is around the costs, and we will update with our half year results. We expect to restore margin through pricing, mix and savings delivery during 2023 and 2024, as market conditions normalise.
Our market context
High input cost inflation has been widespread across our markets and rose further during the first quarter as the war in
In most of the markets in which we operate, market growth was driven by price which had an impact on volumes.
Our priority is sustained, competitive growth, delivered through strong brands and our continued drive for operational excellence across the value chain. Underlying sales growth was 7.3% with 8.3% from price and (1.0)% from volume and all Divisions grew strongly. Price stepped up further from the levels seen in the fourth quarter with some negative impact on volume, most notably in Home Care which took the strongest pricing action, leading to growth of 9.2% over the period.
Beauty & Personal Care grew 7.1% in the quarter, driven by price and continued strong growth in Prestige Beauty and vitamins, minerals and supplements. Foods & Refreshment grew 6.5% through price. Volumes in food solutions and out-of-home ice cream improved as both continued to benefit from channels reopening. This helped offset most of the volume decline in in-home channels which lapped high demand during lockdowns in 2021.
Emerging markets grew by 9.5% with a 10.1% contribution from price, with volumes slightly negative. Pricing in
Turnover increased 11.8% to
In
On 23 March, we commenced the first tranche of
We expect the announced sale of our global tea business to complete in the second half of 2022.
Beauty & Personal Care
Beauty & Personal Care underlying sales grew 7.1%, with 7.4% from price and (0.3)% from volume.
Deodorants posted high single-digit growth, helped by technology-driven innovations behind Dove and Rexona, as well as Axe making a strong start to the year. Hair posted mid single-digit growth driven by both styling and wash & care. Sunsilk and TRESemme contributed strongly with price-led growth while Suave declined. Skin cleansing delivered high single-digit growth with Dove, Lux and Lifebuoy performing well, but volumes declined in a contracting market. Skin care grew low single-digit driven by
Prestige Beauty had another quarter of double digit-growth, on top of a very strong prior year comparator, when the health and beauty channel re-opened. Hourglass and Living Proof started strongly into the year supported by the premium hair and make-up categories bouncing back.
Home Care
Home Care underlying sales grew 9.2%, with 12.5% from price and (2.9)% from volume, lapping a very strong prior year comparator and facing contracting market volumes.
Fabric cleaning achieved a strong start to the year, with double-digit, price-led growth across most markets and volumes declining only marginally. OMO continued to successfully drive the liquids market development in
Home and hygiene saw modest growth, with strong pricing being offset by negative volumes against the backdrop of a strong prior year comparator. Domestos further built on the growth of recent years, led by our bleach portfolio.
Foods & Refreshment
Foods & Refreshment underlying sales grew 6.5%, with 7.1% from price and (0.6)% from volume.
Foods delivered high single-digit growth with strong pricing in all key geographies. Hellmann's posted double-digit growth against a strong baseline in the prior two years, supported by the successful 'Superbowl' campaign. Knorr continued to evolve the portfolio by responding to consumer needs in fast-growing segments such as plant-based innovations in
Ice cream growth in the first quarter was driven by double-digit increases in the out-of-home channel, while in-home sales were slightly down. Out-of-home sales benefitted from the easing of restrictions in
Media Contacts
Press-Office.London@unilever.com
Safe Harbour
Where relevant, these actions are subject to the appropriate consultations and approvals.
This document may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. Forward-looking statements also include, but are not limited to, statements and information regarding the
Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are:
These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the
(C) 2022 Electronic News Publishing, source